At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 22 enrolled
Drug / intervention
Quetiapine XR +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effects of Quetiapine on Sleep During Alcohol Abstinence
In Brief
A Phase 3 clinical trial evaluating Quetiapine XR and Placebo. for Alcoholism and Sleep Initiation and Maintenance Disorders. Completed, enrolled 22 participants across 1 site.
Detailed Summary
The primary purpose of this study is to determine how efficacy of quetiapine (seroquel XR) in improving the sleep in recovering alcohol dependent subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 2007
Enrollment StartAug 2007
Primary CompletionNov 2009
Study CompletionDec 2009
TodayJul 2026
First PostedFeb 14, 2007
Enrollment StartAug 1, 2007
Primary CompletionNov 1, 2009
Study CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 19.4 years ago
Interventions
Quetiapine XRdrug
Quetiapine is a second generation antipsychotic medication, which has also recently shown to be associated with properties of mood stabilization in bipolar disorder.
Placebo.drug
Inactive or inert pill which will be used as a comparator.